These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3703841)

  • 1. [Effect of treatment with glucocorticoids, pyrogenal and lidase on natural immunity in pulmonary tuberculosis patients].
    Mezhebovskiĭ VR
    Probl Tuberk; 1986; (2):34-8. PubMed ID: 3703841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of corticosteroid hormones and pyrogenal on the humoral factors of natural immunity in pulmonary tuberculosis].
    Mezhebovskiĭ VR
    Probl Tuberk; 1981 Jun; (6):25-8. PubMed ID: 7279903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Grigaliunas AP
    Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Specific and nonspecific immunity factors in pulmonary tuberculosis under chemo- and tuberculin therapy].
    Dzholdubaev YD
    Zdravookhr Kirg; 1980; (1):43-6. PubMed ID: 6103614
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI; Pisarevskaia LI; Nikishina EV
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological reactivity during the pathogenetic treatment of experimental tuberculosis].
    Sibirnaia RI; Snitinskaia OS
    Vrach Delo; 1990 Feb; (2):77-9. PubMed ID: 2339563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphotropic therapy with trental in the treatment of chronic herpetic stomatitis].
    Shumskiĭ AV
    Stomatologiia (Mosk); 1997; 76(1):15-7. PubMed ID: 9148507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of chemotherapy combined with the use of tissue preparations on nonspecific immunity in patients with pulmonary tuberculosis].
    Nersesian ON; Bogatyreva EV
    Probl Tuberk; 1990; (1):28-31. PubMed ID: 2336432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of antioxidants and lidase in pulmonary tuberculosis].
    Gur'eva IG; Andrzheiuk NI; Starostenko EV; Smirnova NA; Elistratova NA
    Probl Tuberk; 1988; (1):52-6. PubMed ID: 3362823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levamisole and diucifon immunochemotherapy of chronic destructive pulmonary tuberculosis].
    Khomenko AG; Insanov AB
    Probl Tuberk; 1984 Sep; (9):23-7. PubMed ID: 6504881
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of glucocorticoids in the combined treatment of destructive pulmonary tuberculosis].
    Iareshko AG
    Probl Tuberk; 1983 Feb; (2):44-7. PubMed ID: 6844331
    [No Abstract]   [Full Text] [Related]  

  • 14. Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.
    Tiemessen CT; Shalekoff S; Meddows-Taylor S; Martin DJ
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):686-9. PubMed ID: 11427411
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
    Khomenko AG; Insanov AB
    Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamics of the nonspecific immunity indices during the lymphotropic therapy of children with acute pyelonephritis].
    Illek IaIu; Zuĭ OG; Ganieva MSh
    Urol Nefrol (Mosk); 1993; (5):15-7. PubMed ID: 8310576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of pyrogenal in the combined treatment of torpid destructive forms of pulmonary tuberculosis].
    Bilyk MA; Dudchik GKh
    Vrach Delo; 1982 Jan; (1):29-31. PubMed ID: 7073854
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of bronchial pathology on the results of treatment of pulmonary tuberculosis].
    Shesterina MV; Kim ACh; Agafonnikova KI; Rzhavskov IuV; Barchakhova ZI
    Probl Tuberk; 1974; (8):21-3. PubMed ID: 4409353
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunological characteristics of the side-effects of antibacterial preparations in pulmonary tuberculosis patients].
    Samarash VS
    Vrach Delo; 1986 Nov; (11):25-6. PubMed ID: 3825037
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological indices of tuberculosis patients detected during a visit to a physician and during prophylactic examinations].
    Rakhmetov BR
    Probl Tuberk; 1979 Oct; (10):41-4. PubMed ID: 504108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.